Intealth CEO William W. Pinsky, MD, Announces Retirement Date

Strategic Transformation Marks Tenure

Last Wednesday, Intealth announced that Chief Executive Officer William W. Pinsky, MD, will retire at the end of 2023. At that time, Dr. Pinsky also will retire as the President of ECFMG, a member of Intealth, and the Board Chair of FAIMER^®, a member of Intealth. Dr. Pinsky’s retirement will follow more than seven years of strategic leadership during which he has transformed the organizations and their ability to promote better health care for all.

During his tenure beginning in 2016, Dr. Pinsky reimagined the structure of the organizations, refining governance, expanding the executive leadership team, and instituting progressive realignments of business units to nurture synergies and maximize impact. His unwavering focus on strategy has engaged all levels of the organizations, consisting of both focused, accelerated initiatives and a comprehensive framework to guide and integrate all activities.

This sustained period of transformation resulted in the creation of Intealth in 2021, fulfilling Dr. Pinsky’s vision for the integration of ECFMG and FAIMER to ensure a common focus and the efficient use of resources. As Intealth’s Chief Executive Officer, he has united these member organizations under a common vision, developed their complementary missions, and established a new set of core values to guide internal and external practice.

“Bill has created something powerful—a structure for growth and the potential to do more,” said ECFMG Board Chair Peter F. Buckley, MD. “He has elevated our baseline, creating a stronger foundation to support the future needs of the world’s physicians and other health professionals, medical education and regulatory communities, researchers and policy makers, and the public.”

The business transformation shepherded by Dr. Pinsky already has demonstrated its value. In recent years, Intealth and its members successfully navigated the profound disruptions of the global COVID-19 pandemic, not only ensuring continuity of their services, but also maintaining the momentum of critical initiatives. In 2021, FAIMER marked its 20th anniversary, convening nearly 600 participants from 51 countries to celebrate the success of its fellowship programs for health professions educators and unveiling new initiatives to support the health professions worldwide. In 2022, ECFMG confirmed the 2024 launch of its medical school accreditation initiative, which is vitally important to ensuring the quality of medical education and, ultimately, patient care globally. The organizations also have taken on proactive roles to advocate, share expertise, and inform public policy in order to ensure accessible, high quality health care.

The second half of 2023 will see the launch of MyIntealth™, a new on-line environment offering users streamlined access to services and a vastly enhanced user experience as well as the expansion of FAIMER’s network of Regional Institutes to include one in Eastern Africa.

A national search for Dr. Pinsky’s successor will be initiated in the near future.

Deadline Reminder: Application for Pathways for ECFMG Certification for 2023 Match

International medical students and graduates participating in the National Resident Matching Program^® (NRMP^®) 2023 Main Residency Match^® (The Match^®) must meet the following requirements by the NRMP Rank Order List Certification deadline on March 1, 2023, in order for ECFMG to verify to the NRMP that they have met the examination requirements for ECFMG Certification:

Have passing results available on the Step 1 and Step 2 Clinical Knowledge (CK) components of the United States Medical Licensing Examination^® (USMLE^®) that are valid for ECFMG Certification; AND
Meet the clinical and communication skills requirements for ECFMG Certification, which can be achieved by either:
- Completing an ECFMG Pathway, OR
- Having a passing performance on the former Step 2 Clinical Skills (CS) component of USMLE that is valid for ECFMG Certification.

Pathways applicants must have their applications submitted no later than January 31, 2023, to ensure the application is processed and approved by ECFMG in time to participate in the 2023 Match. To apply to a Pathway, or to check the status of an application after it has been submitted, applicants should log in to the Application for Pathways for ECFMG Certification for 2023 Match using their USMLE/ECFMG ID and On-line Services password. Applicants should also refer to the Requirements for ECFMG Certification for 2023 Match section of the ECFMG website, including the web page specific to the Pathway to which they are applying, for additional deadlines related to the submission of required documentation and to taking the Occupational English Test (OET) Medicine, which is required of all Pathways applicants.

We encourage Pathways applicants to review the detailed information available on ECFMG’s website and to track the status of their requests on-line prior to contacting us. To track the status of:

Pathways applications, applicants should log in to the Application for Pathways for ECFMG Certification for 2023 Match, as described above;
USMLE applications, credentials verifications, and other items related to ECFMG Certification, applicants should log in to the On-line Applicant Status and Information System (OASIS).